Brimonidine Tartrate (Sandoz Inc)


Welcome to the PulseAid listing for the Brimonidine Tartrate drug offered from Sandoz Inc. This Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc
NON-PROPRIETARY NAME: Brimonidine Tartrate
SUBSTANCE NAME: BRIMONIDINE TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2003-09-17
END MARKETING DATE: 0000-00-00


Brimonidine Tartrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBrimonidine Tartrate from Sandoz Inc
LABELER NAME: Sandoz Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 2003-09-17
END MARKETING DATE: 0000-00-00
PRODUCT ID: 61314-143_2d66fa03-f6c8-4eac-9f78-5072ef84e3d3
PRODUCT NDC: 61314-143
APPLICATION NUMBER: ANDA076254

Other BRIMONIDINE TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Brimonidine
Allergan, Inc.ALPHAGAN P
Bausch & Lomb IncorporatedBrimonidine Tartrate
Galderma Laboratories, L.P.Mirvaso
Osmotica Pharmaceutical Corp.Brimonidine Tartrate
Pacific Pharma, Inc.BRIMONIDINE TARTRATE
Physicians Total Care, Inc.ALPHAGAN P
Regimed MedicalBrimonidine Tartrate
Sandoz IncBrimonidine Tartrate
STAT RX USA LLCBRIMONIDINE TARTRATE
Westminster Pharmaceuticals, LLCBrimonidine Tartrate Ophthalmic Solution, 0.2%